🇺🇸 FDA
Patent

US 12227482

Compounds and compositions for the treatment of cancer

granted A61PA61P19/04A61P35/00

Quick answer

US patent 12227482 (Compounds and compositions for the treatment of cancer) held by The Regents of the University of California expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P19/04, A61P35/00, A61P43/00